Canaan Partners

Activity from announced rounds

Activity in this selectionAI

Canaan Partners is an investment firm whose company directory identifies Draig Therapeutics and Solstice Oncology.

Recorded funding activity

Draig develops neuropsychiatric medicines, while Solstice advances an engineered CTLA-4 antibody for cancer treatment. The recorded history also includes Actualyze AI’s enterprise gateway for model access, request security, budgets and routing. Named regional funds retain separate identities.

Sources
Rounds participated in
5
Confirmed lead rounds
1
4 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$88M
5 disclosed · full round size, not this investor’s share

By stage

Seed4
Series A1

By primary sector

AI3
Cybersecurity1
Enterprise software1

By country

United States3
Israel1
Switzerland1

Rounds

5 in this selection
Actualyze AI

An enterprise gateway for AI-model access, request security, budgets and routing.

$7MSeed
Role not disclosed
HeyMilo AI

Builds agentic recruiting platform that screens high-volume candidates via voice, video, SMS, and resume agents

$6MSeed
Role not disclosed
SageOx

Builds shared context infrastructure for AI-native teams

$15MSeed
Role not disclosed
Rapidata

Rapidata supplies on-demand human feedback for training and evaluating AI models.

$8.5MSeed
Lead
Novee

Novee provides AI-powered penetration-testing software.

$51.5MSeries A
Role not disclosed